[Anti-arrhythmia drug therapy from the pharmacologist's viewpoint].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; D011807:Quinolizines; D010672:Phenytoin; D011802:Quinidine; D011342:Procainamide; D011188:Potassium
La medicación antiarrítmica vista por el farmacólogo.